Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health www.cancer.gov
CCR - For Our Staff| Home |

Our Science – Miettinen Website

Markku Martti Miettinen, M.D.

Selected Publications

1)  Lasota J, Wang Z, Kim SY, Helman L, Miettinen M.
Expression of the receptor for type i insulin-like growth factor (IGF1R) in gastrointestinal stromal tumors: an immunohistochemical study of 1078 cases with diagnostic and therapeutic implications.
Am. J. Surg. Pathol. 37: 114-9, 2013.
[Journal]
2)  Miettinen M, Lasota J.
Gastrointestinal stromal tumors.
Gastroenterol. Clin. North Am. 42: 399-415, 2013.
[Journal]
3)  Miettinen M, Killian JK, Wang ZF, Lasota J, Lau C, Jones L, Walker R, Pineda M, Zhu YJ, Kim SY, Helman L, Meltzer P.
Immunohistochemical loss of succinate dehydrogenase subunit A (SDHA) in gastrointestinal stromal tumors (GISTs) signals SDHA germline mutation.
Am. J. Surg. Pathol. 37: 234-40, 2013.
[Journal]
4)  Miettinen M, Sarlomo-Rikala M, Cue PM, Czapiewski P, Langfort R, Waloszczyk P, Wazny K, Biernat W, Lasota J, Wang Z.
Mapping of Succinate Dehydrogenase Losses in 2258 Epithelial Neoplasms.
Appl. Immunohistochem. Mol. Morphol. 2013.
[Journal]
5)  Killian JK, Kim SY, Miettinen M, Smith C, Merino M, Tsokos M, Quezado M, Smith WI, Jahromi MS, Xekouki P, Szarek E, Walker R, Lasota J, Raffeld M, Klotzle B, Wang Z, Jones L, Zhu YJ, Wang Y, Waterfall J, O'Sullivan M, Bibikova M, Pacak K, Stratakis CA, Janeway KA, Schiffman JD, Fan J, Helman LJ, Meltzer PS.
Succinate dehydrogenase mutation underlies global epigenomic divergence in gastrointestinal stromal tumor.
Cancer Discov. [Epub ahead of print], 2013.
[Journal]
6)  Miettinen M.
[Gastrointestinal stromal tumor].
Duodecim. 128: 1441-50, 2012.
[Journal]
7)  Dumont AG, Rink L, Godwin AK, Miettinen M, Joensuu H, Strosberg JR, Gronchi A, Corless CL, Goldstein D, Rubin BP, Maki RG, Lazar AJ, Lev D, Trent JC, von Mehren M.
A nonrandom association of gastrointestinal stromal tumor (GIST) and desmoid tumor (deep fibromatosis): case series of 28 patients.
Ann. Oncol. 23: 1335-40, 2012.
[Journal]
8)  Miettinen M.
A simple method for generating multitissue blocks without special equipment.
Appl. Immunohistochem. Mol. Morphol. 20: 410-2, 2012.
[Journal]
9)  Voltaggio L, Murray R, Lasota J, Miettinen M.
Gastric schwannoma: a clinicopathologic study of 51 cases and critical review of the literature.
Hum. Pathol. 43: 650-9, 2012.
[Journal]
10)  Barak S, Wang Z, Miettinen M.
Immunoreactivity for Calretinin and Keratins in Desmoid Fibromatosis and Other Myofibroblastic Tumors : A Diagnostic Pitfall.
Am J Surg Pathol. 36: 1404-9, 2012.
[Journal]
11)  Aung PP, Sarlomo-Rikala M, Lasota J, Lai JP, Wang ZF, Miettinen M.
KBA62 and PNL2: 2 new melanoma markers-immunohistochemical analysis of 1563 tumors including metastatic, desmoplastic, and mucosal melanomas and their mimics.
Am. J. Surg. Pathol. 36: 265-72, 2012.
[Journal]
12)  Stockman DL, Miettinen M, Suster S, Spagnolo D, Dominguez-Malagon H, Hornick JL, Adsay V, Chou PM, Amanuel B, Vantuinen P, Zambrano EV.
Malignant gastrointestinal neuroectodermal tumor: clinicopathologic, immunohistochemical, ultrastructural, and molecular analysis of 16 cases with a reappraisal of clear cell sarcoma-like tumors of the gastrointestinal tract.
Am. J. Surg. Pathol. 36: 857-68, 2012.
[Journal]
13)  Lai JP, Rosenberg AZ, Miettinen MM, Lee CC.
NY-ESO-1 expression in sarcomas: A diagnostic marker and immunotherapy target.
Oncoimmunology. 1: 1409-1410, 2012.
[Journal]
14)  Lai JP, Robbins PF, Raffeld M, Aung PP, Tsokos M, Rosenberg SA, Miettinen MM, Lee CC.
NY-ESO-1 expression in synovial sarcoma and other mesenchymal tumors: significance for NY-ESO-1-based targeted therapy and differential diagnosis.
Mod. Pathol. 25: 854-8, 2012.
[Journal]
15)  Miettinen M, Wang ZF.
Prox1 transcription factor as a marker for vascular tumors-evaluation of 314 vascular endothelial and 1086 nonvascular tumors.
Am. J. Surg. Pathol. 36: 351-9, 2012.
[Journal]
16)  Miettinen M, Rikala MS, Rys J, Lasota J, Wang ZF.
Vascular endothelial growth factor receptor 2 as a marker for malignant vascular tumors and mesothelioma: an immunohistochemical study of 262 vascular endothelial and 1640 nonvascular tumors.
Am. J. Surg. Pathol. 36: 629-39, 2012.
[Journal]
17)  Purgina B, Rao UN, Miettinen M, Pantanowitz L.
AIDS-Related EBV-Associated Smooth Muscle Tumors: A Review of 64 Published Cases.
Patholog Res Int. 2011: 561548, 2011.
[Journal]
18)  Miettinen M, Sarlomo-Rikala M, Wang ZF.
Claudin-5 as an immunohistochemical marker for angiosarcoma and hemangioendotheliomas.
Am. J. Surg. Pathol. 35: 1848-56, 2011.
[Journal]
19)  Miettinen M, Wang ZF, Paetau A, Tan SH, Dobi A, Srivastava S, Sesterhenn I.
ERG transcription factor as an immunohistochemical marker for vascular endothelial tumors and prostatic carcinoma.
Am. J. Surg. Pathol. 35: 432-41, 2011.
[Journal]
20)  Pelz AF, Agaimy A, Daniels M, Evert M, Schulz HU, Lüders P, Müller G, Lasota J, Röpke A, Wieacker P, Miettinen M, Schneider-Stock R.
Gastrointestinal stromal tumor presenting as a rectovaginal mass. Clinicopathologic and molecular-genetic characterization of a rare tumor with a literature review.
Hum. Pathol. 42: 586-93, 2011.
[Journal]
21)  Miettinen M, Lasota J.
Histopathology of gastrointestinal stromal tumor.
J Surg Oncol. 104: 865-73, 2011.
[Journal]
22)  Patil DT, Laskin WB, Fetsch JF, Miettinen M.
Inguinal smooth muscle tumors in women-a dichotomous group consisting of Müllerian-type leiomyomas and soft tissue leiomyosarcomas: an analysis of 55 cases.
Am. J. Surg. Pathol. 35: 315-24, 2011.
[Journal]
23)  Deyrup AT, Miettinen M, North PE, Khoury JD, Tighiouart M, Spunt SL, Parham DM, Shehata BM, Weiss SW.
Pediatric cutaneous angiosarcomas: a clinicopathologic study of 10 cases.
Am. J. Surg. Pathol. 35: 70-5, 2011.
[Journal]
24)  Wang JH, Lasota J, Miettinen M.
Succinate Dehydrogenase Subunit B (SDHB) Is Expressed in Neurofibromatosis 1-Associated Gastrointestinal Stromal Tumors (Gists): Implications for the SDHB Expression Based Classification of Gists.
J Cancer. 2: 90-3, 2011.
[Journal]
25)  Miettinen M, Wang ZF, Sarlomo-Rikala M, Osuch C, Rutkowski P, Lasota J.
Succinate dehydrogenase-deficient GISTs: a clinicopathologic, immunohistochemical, and molecular genetic study of 66 gastric GISTs with predilection to young age.
Am. J. Surg. Pathol. 35: 1712-21, 2011.
[Journal]
Click Here to View Collapsed Bibliography.

This page was last updated on 5/9/2013.